SCHEMBL11340787

SCHEMBL11340787

Cc1ccc(NC(=O)Nc2ccc(C)c(C(=O)Nc3c(O)ccc4c(S(=O)(=O)O)cccc34)c2)cc1C(=O)Nc1c(O)ccc2c(S(=O)(=O)O)cccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT1 Q99873 2/20 0.41
KDR P35968 2/20 0.41
HPSE Q9Y251 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
ENPP3 O14638 1/20 0.41
ENTPD3 O75355 1/20 0.41
NR1I2 O75469 1/20 0.41
USP2 O75604 1/20 0.41
PRKD3 O94806 1/20 0.41
TDP2 O95551 1/20 0.41
CBX7 O95931 1/20 0.41
NSD2 O96028 1/20 0.41
ESR1 P03372 1/20 0.41
PRKCG P05129 1/20 0.41
CYP1A2 P05177 1/20 0.41
PRKCB P05771 1/20 0.41
HTR1A P08908 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10907419 0.94 BRAF (0.40) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL11338996 0.89 CA12 (0.43) PRMT1KDRKMT2AMEN1CA12
SCHEMBL11342415 0.88 PRMT1 (0.42) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL11339023 0.86 CA12 (0.47) PRMT1KDRKMT2AMEN1CA12
SCHEMBL11344010 0.85 KMT2A (0.41) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL11345079 0.85 HPSE (0.47) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL11340707 0.85 KDR (0.45) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL10823545 0.84 IDH1 (0.55) IDH1IDH2
SCHEMBL11349822 0.83 TNNI3 (0.46) PRMT1KDRHPSEKMT2AMEN1
SCHEMBL11341037 0.83 KMT2A (0.52) PRMT1KDRHPSEKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4297372-A ANTIARTHRITIC AGENTS; COLLAGENASE AND PROTEOLYTIC ENZYME INHIBITORS; BONE, SKIN, AND ORAL DISORDERS AMERICAN CYANAMID COMPANY (US) 1981-10-27 US disclosed
EP-0013784-A1 C-Substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them AMERICAN CYANAMID COMPANY (US) 1980-08-06 EP disclosed
US-4216164-A Ureide inhibitors of connective tissue destruction AMERICAN CYANAMID COMPANY (US) 1980-08-05 US disclosed